In line with down-regulated CYP1A2 mRNA, the reduction of CYP1A2 protein (5.5-fold) was demonstrated by Western blotting assay in the 24 randomly selected HCC cases (Figure 1B). Here, CYP1A2 is linked to hepatocellular carcinoma.